Menu Home About Us About FinVector Management Team Partnerships Careers Facility Services Cell banking and Viral seed stocks Platform Process Development/Scale Up Assay Development and Analytical Testing cGMP Manufacturing Capabilities FinVector Aseptic Filling Capability Stability Studies Viral Vectors (including Adeno, AAV, Lenti) Regulatory News and Events Contact Us “Thanks to FinVector's flexility and pro-activity, our clinical development program has been initiated on-time with high quality products.” Client Testimonial “The FinVector team is always willing to go the extra mile for our team. They frequently assist us with requests and questions.” Client Testimonial “A reliable partner in development, with good interactions on the project with regular project team calls, and delivery on time.” Client Testimonial “We'd like to congratulate FinVector on the way they conducted our manufacturing project - they provided a talented team of professionals to meet our requests.” Client Testimonial cGMP MANUFACTURING AND DEVELOPMENT OF CLINICAL AND COMMERCIAL VIRAL VECTORS OUR SERVICES CELL BANKING AND VIRAL SEED STOCKS PLATFORM PROCESS DEVELOPMENT/ SCALE UP ASSAY DEVELOPMENT AND ANALYTICAL TESTING cGMP MANUFACTURING CAPABILITIES FINVECTOR ASEPTIC FILLING CAPABILITY STABILITY STUDIES VIRAL VECTORS (ADENO, AAV, LENTI) REGULATORY COMPANY VIDEO Commercially licensed cGMP manufacturing facility in Finland LATEST NEWS 3 September 2015 FinVector article accepted in Human Gene Therapy 1 September 2015 FinVector at ESGCT Annual Congress 2015, Helsinki View News and Events An introduction to FinVector FinVector is a world leader in the research and development of Viral-Based Gene Therapy products, with state-of-the-art facilities and a highly experienced scientific team working in the gene therapy market. We deliver a tailored service to meet and exceed our clients’ needs, and use our scientific expertise and industry knowledge to help clients take viral-based products from the pre-clinical phase, through clinical trials and to the market. Useful links Sitemap Cookies Privacy Policy © FinVector Vision Therapies, 2014.